July 10, 2024
Drug Databases Reporting Problems to FDA Learn about the vital tool for reporting serious side effects or product quality problems related to FDA-regulated medical products. Compounding […]
July 10, 2024
On This Page Date: August 30, 2022 Time: 8:30 AM – 5:00 PM ET Event Summary The Centers for Disease Control and Prevention (CDC) and Food […]
July 10, 2024
[7-10-2024] The Food and Drug Administration is advising consumers not to purchase or use Gold Hard Steel Plus, a product promoted and sold for sexual enhancement on […]
July 10, 2024
Drug Info Rounds is a series of educational videos for health care professionals brought to you by the FDA’s Center for Drug Evaluation and Research (CDER), […]
July 10, 2024
(Reuters) -The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over their tactics as middlemen in negotiating prices for drugs including […]
July 10, 2024
Department of JusticeU.S. Attorney’s OfficeSouthern District of New York FOR IMMEDIATE RELEASETuesday, July 9, 2024 U.S. Compounding, Inc., a Subsidiary of a Publicly Traded Company, Pled […]
July 10, 2024
On July 9, the US Food and Drug Administration approved the supplemental new drug application for roflumilast cream 0.15% for the treatment of mild to moderate […]
July 10, 2024
TOPLINE: Over 5 years, dupilumab demonstrated acceptable safety and sustained efficacy, with significant improvements in the signs and symptoms of AD, in the treatment of moderate […]
July 10, 2024
TOPLINE: CCN3, a hormone secreted by neurons in the brain, enhances the density and strength of bone in lactating mice. This discovery could lead to new […]